| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | AKEBIA THERAPEUTICS INC | 70,455 | 648,000 | 0.55% | ||
| 52 | COGENTIX MED INC | 353,482 | 636,000 | 0.54% | ||
| 53 | GEMPHIRE THERAPEUTICS INC | 52,797 | 554,000 | 0.47% | ||
| 54 | Ascendis Pharma | 18,214 | 510,000 | 0.43% | ||
| 55 | INOTEK PHARMACEUTICALS CORP | 237,135 | 474,000 | 0.40% | ||
| 56 | EIGER BIOPHARMACEUTICALS INC | 35,977 | 412,000 | 0.35% | ||
| 57 | Sierra Oncology Inc. | 265,000 | 405,000 | 0.34% | ||
| 58 | CYMABAY THERAPEUTICS INC | 88,067 | 379,000 | 0.32% | ||
| 59 | INOTEK PHARMACEUTICALS CORP | 600,000 | 372,000 | 0.31% | PRN | |
| 60 | ABEONA THERAPEUTICS INC | 67,537 | 338,000 | 0.29% | ||
| 61 | CELYAD SA | 12,528 | 328,000 | 0.28% | ||
| 62 | MASIMO CORP | 3,500 | 326,000 | 0.28% | ||
| 63 | ObsEva SA | 25,000 | 260,000 | 0.22% | ||
| 64 | BELLICUM PHARMACEUTICALS INCORPORATED | 20,000 | 247,000 | 0.21% | ||
| 65 | AXSOME THERAPEUTICS INC COM | 55,700 | 217,000 | 0.18% | ||
| 66 | AFFIMED N V COM | 92,500 | 213,000 | 0.18% | ||
| 67 | Pieris Pharmaceuticals | 53,525 | 139,000 | 0.12% | ||
| 68 | ADAMIS PHARMACEUTICALS CORP | 30,000 | 128,000 | 0.11% | ||
| 69 | ANAPTYSBIO INC | 4,500 | 125,000 | 0.11% | ||
| 70 | TONIX PHARMACEUTICALS HLDG C | 20,000 | 93,000 | 0.08% | ||
| 71 | BioPharmX Corporation | 115,000 | 58,000 | 0.05% | ||
| 72 | GALENA BIOPHARMA INCORPORATED COM NEW | 46,145 | 28,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-17-000018, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
